These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4188590)

  • 1. [Clinical evaluation of a fribrinolytic drug in an experimental cross-over study].
    Bizzi B; Butti A
    Minerva Med; 1969 Dec; 60(99 Suppl):5062-7. PubMed ID: 4188590
    [No Abstract]   [Full Text] [Related]  

  • 2. [Controlled experimental study of the relations between fibrinolytic acitivity and anticoagulant activity in evaluation of activators of fibrinolysis].
    Cascone A; Lampugnani P
    Minerva Med; 1969 Dec; 60(99 Suppl):5039-45. PubMed ID: 4188588
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antilipemic and fibrinolytic activity of an extractive mucopolysaccharide in atherosclerotic disease].
    Isidori A; Butti A; Rossi G
    Minerva Med; 1969 Dec; 60(99 Suppl):5077-81. PubMed ID: 4188592
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action of an extractive heparinoid on some blood coagulation indices].
    Guidi G; Lombardi V; Torsellini A
    Minerva Med; 1969 Dec; 60(99 Suppl):5034-8. PubMed ID: 4188587
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clearing and anti-platelet-aggregation effects of a heparinoid of natural origin].
    Marini U; Bastoni F; Gibelli A
    Clin Ter; 1974 Oct; 71(1):13-31. PubMed ID: 4138995
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effects of oral administration of a sulfo-polysaccharide of low molecular weight in a group of sedentary workers with ateriosclerotic cardiovascular disease].
    Alessandri M; Fiorentini P; Garagnani C
    G Clin Med; 1967 Sep; 48(9):935-47. PubMed ID: 4180085
    [No Abstract]   [Full Text] [Related]  

  • 7. [Electroencephalographic and audiometric controls in presenile and senile arteriosclerotic subjects treated with an extractive sulfomucopolysaccharide complex with fibrinolytic action].
    Sfondrini E; Barberi G
    Minerva Med; 1969 Dec; 60(99 Suppl):5082-6. PubMed ID: 4188593
    [No Abstract]   [Full Text] [Related]  

  • 8. [Modifications of fibrinolysis and coagulation activity in arteriosclerotic patients treated with a polysulfoester of pentosan (SP-54). I].
    Cajozzo A; Citarrella P; Malleo C
    Boll Soc Ital Cardiol; 1971; 16(3):117-26. PubMed ID: 4110180
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the therapeutic indication of SP 54 based on clinical experimental studies].
    Hammerl H; Kränzl C; Pichler O; Studlar M
    Med Welt; 1967 Mar; 11():638-45. PubMed ID: 4172234
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experiences with the vascular action of dihydroergocristine].
    Tomasi AM; Baggioni GF; Pozzar C
    Minerva Cardioangiol; 1975 Jan; 23(1):7-19. PubMed ID: 806854
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes induced by D-thyroxine treatment in blood lipid indices in arteriosclerotic subjects].
    Notarbartolo A; Di Fede G; Cupidi G; Rini GB
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):979-83. PubMed ID: 4463989
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical research on the aged concerning the anti-sclerotic effect of a new heparinoid extract: glycuronoglucosaminoglycan sulfate (3GS)].
    Turpini R; Caliandro L; Cocchi A; Volpi F; Brusaioli G; Grignani G; Antognetti R
    Clin Ter; 1975 May; 73(3):213-36. PubMed ID: 123842
    [No Abstract]   [Full Text] [Related]  

  • 13. [Glucuronyl-glucosaminoglycan sulfate in therapy of atheroarteriosclerotic syndromes in geriatrics].
    Bompani R; Violi G
    Minerva Med; 1974 Nov; 65(83):4315-29. PubMed ID: 4279362
    [No Abstract]   [Full Text] [Related]  

  • 14. [Conservative therapy of arteriosclerotic vascular damage].
    Deutsch E
    Wien Klin Wochenschr; 1969 Jun; 81(23):421-5. PubMed ID: 5790193
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prolonged therapeutic-prophylactic use of anticoagulants].
    Kushelevskiĭ BP; Seliverstova GP
    Klin Med (Mosk); 1973 Apr; 51(4):26-8. PubMed ID: 4704262
    [No Abstract]   [Full Text] [Related]  

  • 16. [Shifts in coagulating and fibrinolytic activity of the blood following the administration of nerobol in patients with coronary atherosclerosis].
    Kratovskaia OV; Zalaldinova NB; Afaunova VI; Denisova TP; Lebedeva SN
    Ter Arkh; 1972 Sep; 44(9):29-31. PubMed ID: 4660396
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of drug preparations used in treating coronary arteriosclerosis on the coagulogram and blood biochemical indices].
    Semavin IE; Goliakov VN; Semiletov VI; Solov'ev VV
    Sov Med; 1979 Jan; (1):31-5. PubMed ID: 424857
    [No Abstract]   [Full Text] [Related]  

  • 18. [Miscleron in the treatment of patients with atherosclerosis of the coronary and cerebal vessels].
    Sivkov II; Kukes VG; Kirichenko LL; Fedosova NS; Ishmaeva KA
    Sov Med; 1971 Sep; 34(9):54-7. PubMed ID: 5121295
    [No Abstract]   [Full Text] [Related]  

  • 19. [The heparin tolerance test in the treatment of regional and diffuse atherosclerotic vascular diseases].
    Guglielmi G; Barlattani M
    Clin Ter; 1971 Aug; 58(3):229-42. PubMed ID: 5135002
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical, biochemical and pathological studies of long term "clofibrate" therapy.
    el-Mehairy MM; Attia O; Nabih AE; Nassar I; Ibrahim WN
    J Trop Med Hyg; 1970 Jul; 73(7):177-81. PubMed ID: 5470220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.